Association Between Antibodies That Bind Epstein-Barr Virus (EBV) gp350 and gH/gL and Shedding of EBV in Saliva From Nasopharyngeal Carcinoma Multiplex Family Members in Taiwan

Elevated levels of Epstein-Barr virus (EBV) gp350 and gH/gL antibodies have been associated with a lower risk of developing nasopharyngeal carcinoma (NPC), although the evidence remains inconclusive and unexplained. We conducted a longitudinal study within a high-risk Taiwanese cohort, analyzing total immunoglobulin against EBV-gp350 and -gH/gL in blood and EBV DNA shedding in saliva. Contrary to our hypothesis-that elevated levels of antibodies previously shown to be associated with a lower NPC risk should result in a decrease in EBV shedding in saliva-higher anti-gp350 antibodies at baseline were significantly associated with detectable EBV DNA in saliva at follow-up (odds ratio [OR], 1.99 [95% confidence interval {CI}, 1.03-3.97]; <i>P</i> = .04). Higher anti-EBV-gH/gL antibodies at baseline were not significantly associated with risk of detectable EBV DNA at follow-up (OR, 0.69 [95% CI, .35-1.32]; <i>P</i> = .26). These findings underscore the complexity of virus-host interactions and emphasize the need for further investigations into their role in EBV-associated diseases.

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2024-08-30
DOI
https://doi.org/10.1093/ofid/ofae464
Citations
5
Primary Topic
Viral-associated cancers and disorders
Type
article
Field-Weighted Citation Impact
1.41

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association Between Antibodies That Bind Epstein-Barr Virus (EBV) gp350 and gH/gL and Shedding of EBV in Saliva From Nasopharyngeal Carcinoma Multiplex Family Members in Taiwan

Anna E. Coghill, K. Liu, Tseng‐Cheng Chen, Wan‐Lun Hsu et al.
5 citations
Open Forum Infectious Diseases
Viral-associated cancers and disorders
1.41
article

Association Between Antibodies That Bind Epstein-Barr Virus (EBV) gp350 and gH/gL and Shedding of EBV in Saliva From Nasopharyngeal Carcinoma Multiplex Family Members in Taiwan

Anna E. Coghill, K. Liu, Tseng‐Cheng Chen, Wan‐Lun Hsu, Zhiwei Liu, Jeffrey I. Cohen, Allan Hildesheim, Jaap M. Middeldorp, Kelly J. Yu, Wei Bu, Cheng‐Ping Wang, Tim Waterboer, Yin‐Chu Chien, Chien‐Jen Chen
article en
5 citations

Abstract

Elevated levels of Epstein-Barr virus (EBV) gp350 and gH/gL antibodies have been associated with a lower risk of developing nasopharyngeal carcinoma (NPC), although the evidence remains inconclusive and unexplained. We conducted a longitudinal study within a high-risk Taiwanese cohort, analyzing total immunoglobulin against EBV-gp350 and -gH/gL in blood and EBV DNA shedding in saliva. Contrary to our hypothesis-that elevated levels of antibodies previously shown to be associated with a lower NPC risk should result in a decrease in EBV shedding in saliva-higher anti-gp350 antibodies at baseline were significantly associated with detectable EBV DNA in saliva at follow-up (odds ratio [OR], 1.99 [95% confidence interval {CI}, 1.03-3.97]; <i>P</i> = .04). Higher anti-EBV-gH/gL antibodies at baseline were not significantly associated with risk of detectable EBV DNA at follow-up (OR, 0.69 [95% CI, .35-1.32]; <i>P</i> = .26). These findings underscore the complexity of virus-host interactions and emphasize the need for further investigations into their role in EBV-associated diseases.

Open Forum Infectious DiseasesVol. 11(9)
Fu Jen Catholic University (TW), National Institutes of Health (US), German Cancer Research Center (DE), Heidelberg University (DE), Moffitt Cancer Center (US), Genomics Research Center, Academia Sinica (TW), Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud (CR), National Taiwan University Hospital (TW), National Institute of Allergy and Infectious Diseases (US), National Cancer Institute (US), Division of Cancer Epidemiology and Genetics, University of Pennsylvania (US), Vrije Universiteit Amsterdam (NL)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Science Council, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 15%
Viral-associated cancers and disorders
1.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.